Dr. Nancy Meulenberg

Nancy Meulenberg is a biomedical researcher whose work spans immunology, virology, and neurobiology, with a strong foundation in HIV-1 antibody responses and vaccine design. Her early contributions center on the structural and immune recognition of the HIV-1 envelope, helping clarify how broadly neutralizing antibodies develop and how viral diversity shapes immune escape.

Her publications highlight expertise in antibody-mediated immunity, viral evolution, and Env-based immunogens, including studies on CD4 binding, gp41 intermediates, and cross-clade neutralization. This work has informed strategies for vaccine development by identifying key epitopes and mechanisms driving neutralization breadth and resistance.

More recent research reflects a shift toward neurobiological questions, including synaptic regulation in autism models and myelination changes linked to psychoactive compounds. This interdisciplinary trajectory demonstrates strength in molecular techniques and translational thinking, bridging infectious disease research with neuroscience and therapeutic exploration.